Hypoxia inducible factor-1-alpha (HIF-1α) is related to both angiogenesis and inflammation in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 945-951

  Brouwer, Elisabeth ^a   Gouw, Annette S H ^a   Posthumus, Marcel D ^a   Van Leeuwen, Miek A ^a   Boerboom, Alexander L ^a   Bijzet, Johan ^a   Bos, Reinhard ^a   Limburg, Piet C ^a   Kallenberg, Cees G M ^a   Westra, Johanna ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

HIF 1 ; Inflammation; Osteoarthritis; Rheumatoid arthritis; Vessels

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BLOOD VESSELS; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 76649107352     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. FEARON U, GRIOSIOS K, FRASER A et al.: Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003; 30: 260-8.
2. CLAVEL G, VALVASON C, YAMAOKA K et al.: Relationship between angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 2006; 17: 202-10.
3. CLAVEL G, BESSIS N, LEMEITER D et al.: Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 2007; 124: 158-64.
4. STORGARD CM, STUPACK DG, JONCZYK A, GOODMAN SL, FOX RI, CHERESH DA: Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest 1999; 103: 47-54.
5. HAAS CS, AMIN MA, RUTH JH et al.: In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum 2007; 56: 2535-48.
6. SEMENZA G: Signal transduction to hypoxiainducible factor 1. Biochem Pharmacol 2002; 64: 993-8.
7. SEMENZA GL: Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007: cm8.
8. HADDAD JJ, HARB HL: Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha. Int Immunopharmacol 2005; 5: 461-83.
9. TAYLOR PC: VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002; 4 (Suppl. 3): S99-107.
10. TAYLOR PC, SIVAKUMAR B: Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2005; 17: 293-8.
11. DISTLER JH, WENGER RH, GASSMANN M et al.: Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2004; 50: 10-23.
12. GABER T, DZIURLA R, TRIPMACHER R, BURMESTER GR, BUTTGEREIT F: Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis 2005; 64: 971-80.
13. WESTRA J, BROUWER E, BOS R et al.: Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci 2007; 1108: 340-8.
14. JEON CH, AHN JK, CHAI JY et al.: Hypoxia appears at pre-arthritic stage and shows colocalization with early synovial inflammation in collagen induced arthritis. Clin Exp Rheumatol 2008; 26: 646-8.
15. HITCHON C, WONG K, MA G, REED J, LYTTLE D, EL GABALAWY H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002; 46: 2587-97.
16. CRAMER T, YAMANISHI Y, CLAUSEN BE et al.: HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003; 112: 645-57.
17. ODA T, HIROTA K, NISHI K et al.: Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 2006; 291: C104-C113.
18. HOLLANDER AP, CORKE KP, FREEMONT AJ, LEWIS CE: Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001; 44: 1540-4.
19. GIATROMANOLAKI A, ARVANITIDOU V, HATZIMICHAEL A, SIMOPOULOS C, SIVRIDIS E: The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas. Pathology 2005; 37: 149-51.
20. HASHIMOTO A, TARNER IH, BOHLE RM et al.: Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection. Arthritis Rheum 2007; 56: 1094-105.
21. LE BA, LIONNETON F, MATTOT V et al.: HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 2007.
22. KATO K, TAKADA T, FUKUSATO T: Expression of vascular endothelial-cadherin in human hepatocellular carcinoma tissues. Hepatol Res 2007; 37: 444-53.
23. KRENN V, MORAWIETZ L, BURMESTER GR et al.: Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 2006; 49: 358-64.
24. ZHONG H, DE MARZO AM, LAUGHNER E et al.: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5.
25. BRESNIHAN B, GERLAG DM, ROONEY T et al.: Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J Rheumatol 2007; 34: 620-2.
26. GERLAG DM, HARINGMAN JJ, SMEETS TJ et al.: Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3783-91.
27. HARINGMAN JJ, GERLAG DM, ZWINDERMAN AH et al.: Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 834-8.
28. ZHONG H, AGANI F, BACCALA AA et al.: Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res 1998; 58: 5280-4.
29. GIATROMANOLAKI A, SIVRIDIS E, MALTEZOS E et al.: Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003; 5: R193-R201.
30. STEVENS CR, BLAKE DR, MERRY P, REVELL PA, LEVICK JR: A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991; 34: 1508-13.
31. FRASER A, FEARON U, REECE R, EMERY P, VEALE DJ: Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001; 44: 2024-8.
32. KOCH AE: Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003; 62 (Suppl. 2): ii60-ii67.
33. CLAVEL G, BESSIS N, BOISSIER MC: Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003; 70: 321-6.
34. MARUOTTI N, CANTATORE FP, CRIVELLATO E, VACCA A, RIBATTI D: Angiogenesis in rheumatoid arthritis. Histol Histopathol 2006; 21: 557-66.
35. WALSH DA, WADE M, MAPP PI, BLAKE DR: Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998; 152: 691-702.
36. PESSLER F, OGDIE A, AZ-TORNE C et al.: Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies. Ann Rheum Dis 2008; 67: 162-7.
37. BROWN JM, GIACCIA AJ: Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 1994; 65:95-102.
38. CHI JT, WANG Z, NUYTEN DS et al.: Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006; 3:e47.